SeaStar Medical Holding Corporation (ICU)
ICU Stock Price Chart
Explore SeaStar Medical Holding Corporation interactive price chart. Choose custom timeframes to analyze ICU price movements and trends.
ICU Company Profile
Discover essential business fundamentals and corporate details for SeaStar Medical Holding Corporation (ICU) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Mar 2021
Employees
19.00
Website
https://www.seastarmedical.comCEO
Eric Schlorff
Description
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.
ICU Financial Timeline
Browse a chronological timeline of SeaStar Medical Holding Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.97, while revenue estimate is $486.50k.
Earnings released on 13 May 2026
EPS came in at -$0.90 falling short of the estimated -$0.73 by -23.29%, while revenue for the quarter reached $495.00k , beating expectations by +13.14%.
Earnings released on 25 Mar 2026
EPS came in at -$0.80 surpassing the estimated -$0.97 by +17.53%, while revenue for the quarter reached $420.00k , beating expectations by +88.76%.
Stock split effective on 5 Jan 2026
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2025
EPS came in at -$1.30 surpassing the estimated -$1.50 by +13.33%, while revenue for the quarter reached $183.00k , missing expectations by -26.80%.
Earnings released on 13 Aug 2025
EPS came in at -$0.18 surpassing the estimated -$0.43 by +58.14%, while revenue for the quarter reached $338.00k , beating expectations by +37.96%.
Earnings released on 14 May 2025
EPS came in at -$0.44 surpassing the estimated -$0.52 by +15.38%, while revenue for the quarter reached $293.00k , beating expectations by +95.33%.
Earnings released on 27 Mar 2025
EPS came in at -$0.90 falling short of the estimated -$0.89 by -1.12%, while revenue for the quarter reached $67.00k , missing expectations by -55.33%.
Earnings released on 13 Nov 2024
EPS came in at -$1.10 surpassing the estimated -$1.13 by +2.65%, while revenue for the quarter reached $68.00k , missing expectations by -54.67%.
Earnings released on 13 Aug 2024
EPS came in at -$1.03 surpassing the estimated -$1.41 by +26.95%.
Stock split effective on 10 Jun 2024
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2024
EPS came in at -$4.75 falling short of the estimated -$0.15 by -3.07k%.
Earnings released on 13 Mar 2024
EPS came in at -$0.22 falling short of the estimated -$0.13 by -69.23%.
Earnings released on 14 Nov 2023
EPS came in at -$3.00 falling short of the estimated -$0.25 by -1.10k%.
Earnings released on 14 Aug 2023
EPS came in at -$6.25 falling short of the estimated -$0.25 by -2.40k%.
Earnings released on 15 May 2023
EPS came in at -$10.00 falling short of the estimated -$5.00 by -100.00%.
Earnings released on 30 Mar 2023
EPS came in at -$160.97 .
Earnings released on 30 Sept 2022
EPS came in at -$36.29 .
Earnings released on 16 Aug 2022
EPS came in at -$17.30 .
Earnings released on 31 Mar 2022
EPS came in at -$19.26 .
Earnings released on 31 Dec 2021
EPS came in at -$23.35 .
Earnings released on 30 Sept 2021
EPS came in at -$23.14 .
ICU Stock Performance
Access detailed ICU performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
